C3bot peptides as drugs for the treatment of traumatic or degenerative neuronal injury
Peptide fragments of the C3 exoenzyme of Clostridium botulinum have been found to have neuritogenic effects on neurons as well as regenerative properties in an animal model (mouse). The peptides represent promising drug candidates for the treatment of neurodegenerative disorders such as Morbus Alzheimer, Parkinson, Huntington chorea but also for spinal cord injury and traumatic brain injury.
Weitere Informationen: PDF
ipal GmbH
Tel.: +49 (0)30/2125-4820
Ansprechpartner
Ursula Haufe
